Interleukin-18 (IL-18) engineered for half-life extension and resistance to IL-18 binding protein (IL-18BP) to enhance anti-cancer therapeutic potential
Titel:
Interleukin-18 (IL-18) engineered for half-life extension and resistance to IL-18 binding protein (IL-18BP) to enhance anti-cancer therapeutic potential
Auteur:
Dreaden, Kristiana H. Pearson, Su-Ping Gurel, Pinar S. Newman, Robert G. Zhao, Yanchun Wang, Chunhua Heiber, Joshua F. Donatelli, Sarah S. Chamoun, Jean Whitmore, Mark M.